- Home
- SGMO vs AXR Comparison
SGMO vs AXR Comparison
Compare SGMO & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- AXR
- Stock Information
- Founded
- SGMO 1995
- AXR 1961
- Country
- SGMO United States
- AXR United States
- Employees
- SGMO N/A
- AXR N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- AXR Homebuilding
- Sector
- SGMO Health Care
- AXR Real Estate
- Exchange
- SGMO Nasdaq
- AXR Nasdaq
- Market Cap
- SGMO 122.8M
- AXR 114.8M
- IPO Year
- SGMO 2000
- AXR N/A
- Fundamental
- Price
- SGMO $0.58
- AXR $21.55
- Analyst Decision
- SGMO Buy
- AXR
- Analyst Count
- SGMO 6
- AXR 0
- Target Price
- SGMO $4.50
- AXR N/A
- AVG Volume (30 Days)
- SGMO 7.8M
- AXR 9.5K
- Earning Date
- SGMO 08-07-2025
- AXR 09-12-2025
- Dividend Yield
- SGMO N/A
- AXR N/A
- EPS Growth
- SGMO N/A
- AXR 89.60
- EPS
- SGMO N/A
- AXR 2.37
- Revenue
- SGMO $81,706,000.00
- AXR $49,694,000.00
- Revenue This Year
- SGMO $1.29
- AXR $124,160.48
- Revenue Next Year
- SGMO $1.60
- AXR $8.16
- P/E Ratio
- SGMO N/A
- AXR $9.09
- Revenue Growth
- SGMO 565.52
- AXR N/A
- 52 Week Low
- SGMO $0.41
- AXR $17.60
- 52 Week High
- SGMO $3.18
- AXR $39.68
- Technical
- Relative Strength Index (RSI)
- SGMO 58.57
- AXR 43.53
- Support Level
- SGMO $0.50
- AXR $21.94
- Resistance Level
- SGMO $0.58
- AXR $22.65
- Average True Range (ATR)
- SGMO 0.05
- AXR 0.64
- MACD
- SGMO 0.00
- AXR -0.09
- Stochastic Oscillator
- SGMO 84.21
- AXR 2.82
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.